Development of candidate drugs for the treatment of Alzheimer's disease: I. investigation of metal chelators as inhibitors of the beta-amyloid aggregation; II. development of tacrine-ibuprofen hybrids

Research Categorization
Researcher and Organization
Principal Investigator
Principal Investigator First Name
Wanda Pereira
Principal Investigator Last Name
Almeida
Contact PI Country
Project Detail
Funding Opportunity Announcement
FY Overall Cost
$67,752
Funding Organization
Agency/Funding Organization
Funding Organization Country